{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:53:23Z","timestamp":1785894803508,"version":"3.56.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100386"],"award-info":[{"award-number":["81100386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170077"],"award-info":[{"award-number":["82170077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.molimm.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:21:39Z","timestamp":1781346099000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of PI3K rebalanced Th1\/Th17\/Treg and restored macrophage function in imiquimod-induced psoriasis"],"prefix":"10.1016","volume":"196","author":[{"given":"Di","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhen","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruojing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-7887","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.molimm.2026.06.004_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.molimm.2026.06.004_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/bjd.12271","article-title":"Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin","volume":"169","author":"Buerger","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.molimm.2026.06.004_bib5","first-page":"854","article-title":"Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPAR\u03b2\/\u03b4 in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis Model","volume":"96","author":"Chamcheu J","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.molimm.2026.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102435","article-title":"Selective targeting of PI3K\u03b4 suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases","volume":"111","author":"Chen","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13287-025-04375-6","article-title":"Immunomodulatory interactions between mesenchymal stromal\/stem cells and immune cells in psoriasis: therapeutic potential and challenges","volume":"16","author":"Dashti","year":"2025","journal-title":"Stem Cell. Res. Ther."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000840","article-title":"Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia","volume":"7","author":"Faehling","year":"2023","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054895","article-title":"Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis","volume":"8","author":"Furuhashi","year":"2013","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.molimm.2026.06.004_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1523-1747.ep12363613","article-title":"MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions","volume":"101","author":"Gillitzer","year":"1993","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2026.06.004_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of Psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2026.06.004_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The Role of Helper T Cells in Psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23220","article-title":"Hydrogen sulfide attenuates uranium-induced kidney cells pyroptosis via upregulation of PI3K\/AKT\/mTOR signaling","volume":"37","author":"Hu","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.molimm.2026.06.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110448","article-title":"Sipeimine attenuates PM2.5-induced lung toxicity via suppression of NLRP3 inflammasome-mediated pyroptosis through activation of the PI3K\/AKT pathway","volume":"376","author":"Huang","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/rheumatology\/keaa410","article-title":"A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sj\u00f6gren's syndrome","volume":"60","author":"Juarez","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031693","article-title":"Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential","volume":"23","author":"Karagianni","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5455\/medarh.2014.68.236-238","article-title":"Immunophenotype lymphocyte of peripheral blood in patients with psoriasis","volume":"68","author":"Karamehic","year":"2014","journal-title":"Med. Arch."},{"issue":"11","key":"10.1016\/j.molimm.2026.06.004_bib20","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2019.05.010","article-title":"Caspase-11-mediated cell death contributes to the pathogenesis of imiquimod-induced Psoriasis","volume":"139","author":"Kenealy","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2026.06.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125325","article-title":"Transcutaneous delivery of disease-specific PI3K\/Akt\/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies","volume":"672","author":"Keshari","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.molimm.2026.06.004_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1346-8138.14733","article-title":"Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization","volume":"46","author":"Kim","year":"2019","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"22","key":"10.1016\/j.molimm.2026.06.004_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26227014","article-title":"Leucosceptoside A from Devil's Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K\/AKT Signaling Pathway in Keratinocytes","volume":"26","author":"Koycheva","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.molimm.2026.06.004_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2026.06.004_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00403-021-02207-0","article-title":"Macrophages in dermatology: pathogenic roles and targeted therapeutics","volume":"314","author":"Kuraitis","year":"2022","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030730","article-title":"The Balance of Th17 versus Treg Cells in Autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/path.4786","article-title":"Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes","volume":"240","author":"Leite Dantas","year":"2016","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.molimm.2026.06.004_bib30","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jid.2018.12.035","article-title":"Dysregulation of Akt-FOXO1 Pathway Leads to Dysfunction of Regulatory T Cells in Patients with Psoriasis","volume":"139","author":"Li","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2026.06.004_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2013.08.051","article-title":"PI3K\u03b3 inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice","volume":"253","author":"Li","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.molimm.2026.06.004_bib32","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2147\/CCID.S389760","article-title":"Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)\/Protein Kinase B (AKT) Signaling Pathway","volume":"15","author":"Li","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.coph.2013.05.013","article-title":"Changes in macrophage phenotype as the immune response evolves","volume":"13","author":"Lichtnekert","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jdermsci.2018.05.009","article-title":"Treatment with TNF-\u03b1 inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation","volume":"91","author":"Lin","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.molimm.2026.06.004_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101248","article-title":"Gasdermin D-mediated neutrophil pyroptosis drives inflammation in psoriasis","volume":"13","author":"Liu","year":"2024","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.molimm.2026.06.004_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7215072","article-title":"Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis","volume":"2017","author":"Lorthois","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molimm.2026.06.004_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3069521","article-title":"Notch1 Signaling Regulates the Th17\/Treg Immune Imbalance in Patients with Psoriasis Vulgaris","volume":"2018","author":"Ma","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"10","key":"10.1016\/j.molimm.2026.06.004_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102636","article-title":"PI3K\u03b4 Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis","volume":"10","author":"Mercurio","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.molimm.2026.06.004_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","article-title":"Activated PI3 kinase delta syndrome: from genetics to therapy","volume":"9","author":"Michalovich","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2026.06.004_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.molimm.2026.06.004_bib42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","article-title":"Tissue regulatory T cells: regulatory chameleons","volume":"21","author":"Mu\u00f1oz-Rojas","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2026.06.004_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","article-title":"Signaling by the phosphoinositide 3-kinase family in immune cells","volume":"31","author":"Okkenhaug","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2026.06.004_bib45","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.molimm.2026.06.004_bib46","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1021\/acs.jmedchem.8b01298","article-title":"Evolution of PI3K\u03b3 and \u03b4 Inhibitors for Inflammatory and Autoimmune Diseases","volume":"62","author":"Perry","year":"2019","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.molimm.2026.06.004_bib47","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1021\/acs.jmedchem.1c00434","article-title":"Discovery of AZD8154, a Dual PI3K\u03b3\u03b4 Inhibitor for the Treatment of Asthma","volume":"64","author":"Perry","year":"2021","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/09674845.2016.1207869","article-title":"Immunophenotyping of T cells in the peripheral circulation in psoriasis","volume":"73","author":"Priyadarssini","year":"2016","journal-title":"Br. J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/15569527.2022.2127750","article-title":"TRIM22 actives PI3K\/Akt\/mTOR pathway to promote psoriasis through enhancing cell proliferation and inflammation and inhibiting autophagy","volume":"41","author":"Ren","year":"2022","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"6","key":"10.1016\/j.molimm.2026.06.004_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis Pathogenesis and Treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.molimm.2026.06.004_bib51","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.4049\/jimmunol.1103173","article-title":"Blockade of phosphatidylinositol 3-kinase PI3K\u03b4 or PI3K\u03b3 reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis [J","volume":"189","author":"Roller","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.molimm.2026.06.004_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121671","article-title":"The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds","volume":"12","author":"Roy","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.molimm.2026.06.004_bib53","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2009-07-232330","article-title":"PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans","volume":"115","author":"Soond","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4049\/jimmunol.2000043","article-title":"Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation","volume":"205","author":"Stark","year":"2020","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2026.06.004_bib55","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8","article-title":"Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces","volume":"32","author":"Vanbervliet","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2026.06.004_bib57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00015550410034444","article-title":"Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis","volume":"84","author":"Vestergaard","year":"2004","journal-title":"Acta Derm. Venereol."},{"issue":"8","key":"10.1016\/j.molimm.2026.06.004_bib58","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1172\/JCI27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.molimm.2026.06.004_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1744-313X.2007.00734.x","article-title":"A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis","volume":"35","author":"Wang","year":"2008","journal-title":"Int. J. Immunogenet."},{"issue":"4","key":"10.1016\/j.molimm.2026.06.004_bib60","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2133.2010.10129.x","article-title":"Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice","volume":"164","author":"Ward","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.molimm.2026.06.004_bib61","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.chembiol.2013.09.017","article-title":"PI3K-\u03b4 and PI3K-\u03b3 inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models","volume":"20","author":"Winkler","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molimm.2026.06.004_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103351","article-title":"AIM2 deficiency in CD4(+) T cells promotes psoriasis-like inflammation by regulating Th17-Treg axis via AIM2-IKZF2 pathway","volume":"150","author":"Xin","year":"2025","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.molimm.2026.06.004_bib63","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jid.2017.12.028","article-title":"Expression of PI3K Signaling Associated with T Cells in Psoriasis Is Inhibited by Seletalisib, a PI3K\u03b4 Inhibitor, and Is Required for Functional Activity","volume":"138","author":"Yager","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.molimm.2026.06.004_bib64","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1016\/j.apsb.2024.06.008","article-title":"Macrophage P2Y(6)R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses","volume":"14","author":"Yin","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.molimm.2026.06.004_bib65","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2026.06.004_bib66","doi-asserted-by":"crossref","first-page":"19911","DOI":"10.1002\/jcp.28589","article-title":"Phosphoinositide 3-kinase\/protein kinase B inhibition restores regulatory T cell's function in pulmonary sarcoidosis","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molimm.2026.06.004_bib67","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.2147\/DDDT.S333372","article-title":"Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia\/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K\/Akt Signal Pathway","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug. Des. Devel Ther."},{"issue":"3","key":"10.1016\/j.molimm.2026.06.004_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/sji.12404","article-title":"Characterization of Th17 and FoxP3(+) Treg Cells in Paediatric Psoriasis Patients","volume":"83","author":"Zhang","year":"2016","journal-title":"Scand. J. Immunol."},{"issue":"22","key":"10.1016\/j.molimm.2026.06.004_bib69","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.21037\/atm-21-3329","article-title":"Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"44","key":"10.1016\/j.molimm.2026.06.004_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305073","article-title":"Copper-bacteriochlorin nanosheet as a specific pyroptosis inducer for robust tumor immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.molimm.2026.06.004_bib71","doi-asserted-by":"crossref","first-page":"10590","DOI":"10.1096\/fj.202000384R","article-title":"C5a\/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from \u03b3\u03b4-T cells","volume":"34","author":"Zheng","year":"2020","journal-title":"Faseb J."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026001379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026001379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:37:10Z","timestamp":1785893830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589026001379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"alternative-id":["S0161589026001379"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2026.06.004","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of PI3K rebalanced Th1\/Th17\/Treg and restored macrophage function in imiquimod-induced psoriasis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}